UROSULF Filmtablette Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

urosulf filmtablette

tad pharma gmbh - sulfamethizol, sulfaethidol - filmtablette - sulfamethizol 350.mg; sulfaethidol 150.mg

HARNOSAL Dragees Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

harnosal dragees

tad pharma gmbh - sulfamethizol, sulfaethidol - dragees - sulfamethizol 0.35mg; sulfaethidol 0.15mg

UROSULF Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

urosulf

tad pharma gmbh (3044021) - sulfamethizol; sulfaethidol - filmtablette - sulfamethizol (2890) 350 milligramm; sulfaethidol (2891) 150 milligramm

RUFOL 100 mg, comprimé Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

rufol 100 mg, comprimé

mylan medical sas - sulfaméthizol 100 mg - comprimé - 100 mg - pour un comprimé > sulfaméthizol 100 mg - antibiotique antibactérien de la famille des sulfamides - classe pharmacothérapeutique : antibiotique antibactérien de la famille des sulfamides - code atc : j : anti-infectieux.ce médicament est un antiseptique urinaire indiqué pour le traitement de certaines infections urinaires à colibacilles, chez la femme et la jeune fille de plus de 12 ans.

urobiotic- oxytetracycline hydrochloride, sulfamethizole and phenazopyridine hydrochloride capsule USA - engelsk - NLM (National Library of Medicine)

urobiotic- oxytetracycline hydrochloride, sulfamethizole and phenazopyridine hydrochloride capsule

roerig - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline - unii:x20i9en955, oxytetracycline - unii:x20i9en955, oxytetracycline - unii:x20i9en955), sulfamethizole (unii: 25w8454h16) (sulfamethizole - unii:25w8454h16, sulfamethizole - unii:25w8454h16, sulfamethizole - unii:25w8454h16), phenazopyridine hydrochloride (unii: 2iuy41693z) (phenazopyridine - unii:, phenazopyridine - unii:, phenazopyridine - unii:) - capsule - based on a review of this drug by the national academy of sciences-national research council and/or other information, fda has classified the indications as follows: "lacking substantial evidence of effectiveness as a fixed combination": urobiotic-250 is indicated in the therapy of a number of genitourinary infections caused by susceptible organisms. these infections include the following: pyelonephritis, pyelitis, ureteritis, cystitis, prostatitis, and urethritis. since both terramycin and sulfamethizole provide effective levels in blood, tissue, and urine, urobiotic-250 provides a multiple antimicrobial approach at the site of infection. both antibacterial components are active against the most common urinary pathogens, including escherichia coli, pseudomonas aeruginosa, aerobacter aerogenes, streptococcus faecalis, streptococcus hemolyticus , and micrococcus pyogenes . urobiotic-250 is particularly useful in the treatment of infections caused by bacteria more sensitive to the combination than to either com

消發米塞唑 Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

消發米塞唑

東信化學藥品有限公司 台北市吉林路45號6樓 (11328755) - sulfamethizole - (粉) - 主成分 () ; sulfamethizole (0824001400) - sulfamethizole - 對磺胺製劑敏感之細菌所引起之炎症

"人生"益樂道錠250公絲 Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"人生"益樂道錠250公絲

人生製藥股份有限公司 台中市西屯區工業區五路3號 (58003103) - sulfamethizole - 錠劑 - sulfamethizole (0824001400) 250mg - sulfamethizole - 尿道感染症、急、慢性淋病、龜頭炎、軟性下疳、泌尿生殖器、手術前後之感染預防